Crinetics Pharmaceuticals Retained Earnings (Accumulated Deficit) 2017-2024 | CRNX
Crinetics Pharmaceuticals retained earnings (accumulated deficit) from 2017 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.